Find More Contacts for Galapagos
Protected Content
Executive VP, General Counsel
Non-Management, Executive Legal
2 emails found
View contacts for Galapagos to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email dpo@glpg.com
  • Phone Number +32 15 34 29 00
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

Lists Featuring This Company

Europe Companies that Exited (Top 10K)
9,946 Number of Organizations • $793B Total Funding Amount • 19,856 Number of Investors
Health Care Companies With More Than $10M in Revenue (Top 10K)
10,000 Number of Organizations • $747B Total Funding Amount • 19,460 Number of Investors
Europe Companies With Fewer Than 1000 Employees (Top 10K)
9,881 Number of Organizations • $599B Total Funding Amount • 61,259 Number of Investors
Europe, Middle East, and Africa (EMEA) Companies With Less Than $1B in Revenue (Top 10K)
9,911 Number of Organizations • $883.2B Total Funding Amount • 63,259 Number of Investors

Frequently Asked Questions

Where is Galapagos's headquarters? Galapagos is located in Mechelen-bovelingen, Limburg, Belgium.Who invested in Galapagos? Galapagos has 6 investors including Gilead Sciences and University of Antwerp.How much funding has Galapagos raised to date? Galapagos has raised .When was the last funding round for Galapagos? Galapagos closed its last funding round on Jul 14, 2019 from a Post-IPO Equity round.Who are Galapagos's competitors? Alternatives and possible competitors to Galapagos may include HealxAffimed, and Lineage Cell Therapeutics.